About us
The Department of Preclinical Imaging and Radiopharmacy is one of five Departments within the Radiology at the University Hospital Tübingen (UKT).
Herein, the Werner Siemens Imaging Center funded by the Swiss Werner Siemens Foundation has evolved from a small laboratory into a leading international imaging science center over the last 10 years. The interdisciplinary nature of our team is mirrored in the variety of research areas covered by the Werner Siemens Imaging Center.
We invite you to screen our web pages to learn about our research and the fascinating options that preclinical and molecular imaging offers.
Latest News
Dr. André Martins honored with Sofja Kovalevskaja Award (Alexander von Humboldt Foundation) 2020
Dr. André Martins, group leader ot the Hyperpolarized & Multimodal Contrast Imaging Science group, is one of this year's recipients of the Alexander von Humboldt Foundation's Sofja Kovalevskaja Award. This award, one of the highest endowed science awards in Germany, honors talented early-career international researchers. It provides up to 1.65 million euros for a five-year research project and enables establishing an independent research group at a research institution in Germany.
Schluchsee Meeting - Joint WSIC and PSI/ETH Symposium
On the 6th and 7th of February, twenty-one scientists of the Paul Scherrer Institut (PSI) and the Werner Siemens Imaging Center (WSIC) met to discuss and plan future joint projects.
During those two days of fruitful discussions in a cooperative atmosphere on the banks of the Schluchsee (Black forest), new projects in the fields of molecular functional imaging of infectious diseases, neuronal networks and immune-cell targeted imaging were identified. These projects will strengthen our long-term relationship with the PSI/ETH and bundle the expertises of two international renowned institutions.
Joint Tübingen - Stanford Symposium: Imaging Cancer Immunotherapy
On the 24th of January twenty-five outstanding researchers of both universities met at the University Campus of Stanford, CA to exchange, discuss and develop new ideas in the field of imaging cancer immunotherapy.
There has been extensive recent progress in the development and success of immunotherapies for various types of cancer. ImmunoPET has emerged as a technique well suited towards addressing the challenges inherent to monitoring immune response. For this antibodies are valuable tools for imaging of immune cells. Due to their biological origin, their large size and delicate structure hampering complete characterization, production of antibody-based radiotracers requires significantly more effort and financial resources compared to small-molecule tracers.
